A prospective, nonrandomized, open-labeled pilot study investigating the use of magnesium in patients undergoing nonacute percutaneous coronary intervention with stent implantation

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 8, Issue 3, 2003, Pages 193-200

  Rukshin, Vladimir ^b   Santos, Raul ^b   Gheorghiu, Mitch ^b   Shah, Prediman K ^b   Kar, Saibal ^b   Padmanabhan, Sriram ^b   Azarbal, Babak ^b   Tsang, Vivian T ^b   Makkar, Raj ^b   Samuels, Bruce ^b   Lepor, Norman ^b   Geft, Ivor ^b   Tabak, Steve ^b   Khorsandhi, Mehran ^b   Buchbinder, Neil ^b   Eigler, Neil ^b   Cercek, Bojan ^b   Hodgson, Keta ^b   Kaul, Sanjay ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

Antithrombotic effects; Magnesium; Percutaneous coronary intervention; Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; MAGNESIUM SULFATE;

ADULT; ANGIOGRAPHY; ARTICLE; BLEEDING; BLOOD PRESSURE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FATALITY; DRUG INFUSION; DRUG SAFETY; DRUG USE; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART RATE; HUMAN; HYPOTENSION; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0141678286     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840300800304     Document Type: Article

References (16)

1. Ravn HB, Kristensen SD, Hjortdal VE, et al. Early administration of intravenous magnesium inhibits arterial thrombus formation. Arterioscler Thromb Vasc Biol 17: 3620-3625, 1997
2. Gawaz M, Ott I, Reininger AJ, et al. Effects of magnesium on platelet aggregation and adhesion: Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost 72:912-918, 1994
3. Rukshin V, Azarbal B, Shah PK, et al. Intravenous magnesium in experimental stent thrombosis in swine. Arterioscler Thromb Vasc Biol 21(9):1544-1549, 2001
4. Rukshin V, Shah PK, Cercek B, et al. Comparative antithrombotic effects of magnesium sulfate and platelet GP IIb/IIIa inhibitors, tirofiban and eptifibatide, in a canine model of stent thrombosis. Circulation 105:1970-1975, 2002
5. Woods KL, Fletcher S, Roffe C, et al. Intravenous magnesium sulphate in suspected acute myocardial infarction: Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339:1553-1558, 1992
6. ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected myocardial infarction. Lancet 345:669-685, 1995
7. Santoro G, Antoniucci D, Bolognese L, et al. A randomized study of intravenous magnesium in acute myocardial infarction treated with direct coronary angioplasty. Am Heart J 40:891-897, 2000
8. Cardinal DC, Flower RJ. The electronic aggregometer: A novel device for assessing platelet behavior in blood. J Pharmacol Methods 3:135-158, 1980
9. Shattil S, Cunningham M, Hoxie J. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70:307-315, 1987
10. Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial-Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 11:1-11, 1988
11. Baim DS, Cutlip DE, Sharma SK, et al. Final results of the Balloon vs Optimal Atherectomy Trial (BOAT). Circulation 97:322-331, 1998
12. Stone GW, Mehran R, Dangas G, et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: A device-specific analysis of 7147 patients. Circulation 104:642-647, 2001
13. Elin RJ. Determination of serum magnesium concentration by clinical laboratories. Magnes Trace Elem 92:60-66, 1991
14. Shecter M, Merz NB, Paul-Labrador M, et al. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am J Cardiol 84(2):152-156, 1999
15. Gawaz M, Seyfarth M, Muller I, et al. Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement. Am J Cardiol 87:332-336, 2001
16. Seyfarth HJ, Koksch M, Roethig G, et al. Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation. Am Heart J 143:118-123, 2002